
Important Dates
|
Other links of interest to meeting participants: |
Dear Colleague,
On July 19 to 24th , 2009 we will host the 5th International Veterinary Vaccines and Diagnostics Conference (IVVDC) in Madison, WI USA. The First IVVDC Conference was held in Madison WI in 1997 (Chair R.D. Schultz), the 2nd in Oxford England 2000 (Chair Lewis Thomas), the 3rd in Guelph Canada 2003 (Chair Pat Shewen) and the 4th in Oslo Norway 2006 (Chair Arve Lund). These were all excellent conferences! The original and continuing purpose of the IVVDC is to bring together people from the Private Sector (Industry, Veterinary Practice and the Public Sector (Government and Academia) to discuss issues pertaining to the development and use of all Veterinary Vaccines and Diagnostics for multiple animal species. We decided to hold the 5th IVVDC again in Madison WI to honor many of the individuals, including those that have retired, who have made and continue to make major contributions to Veterinary Immunology and Microbiology and especially to those that have made major contributions in Veterinary Vaccinology and Diagnostics.
This Conference Series without exception provides more information on vaccines and diagnostics for all veterinary species than any other meeting you can attend.
This years’ conference, similar to previous years, will have concurrent Sessions on Vaccines and Diagnostics for multiple species including: Avian and Aquatic, Bovine, Canine and Feline, Equine, Human, Porcine, Wild and Exotic. Presentations include information on vaccines that not only control or prevent infectious diseases caused by Viruses, Bacteria and/or Parasites, but also vaccines designed for treating, controlling and/or preventing Cancers, Periodontal Disease, Pregnancy, Snakebites, etc.
Sessions will also include: Regulations and Licensing; Immunologic Reagents; Food Safety; Basic Immunology (Adaptive and Innate Immunity); Bioterrorism; Foreign Animal Diseases; Adverse Reactions and/or Undesirable Consequences from Vaccines and/or Diagnostics; Marker (DIVA) Vaccines; Herd (Population) Immunity; Specific Disease Eradication Programs; Development of both New Traditional, and Recombinant DNA, Infectious and Non-Infectious Vaccines; Natural Immunization; Traditional and Molecular Methods for Discovery and Diagnosis.
You will not want to miss this conference because the information will be presented by experts from around the world with many years of experience on the topics they present. Also the audience will include many with years of experience in vaccinology, which will provide an opportunity for many very interesting discussions.
The 5th IVVDC is Sponsored by the Following Organizations:
International Veterinary Vaccines and Diagnostics Committee, American Association of Veterinary Immunologists, Veterinary Immunology Committee, AAHA’s Canine Vaccine Task Force, American Association of Feline Practitioners (AAFP) Vaccine Task Force and World Small Animal Veterinary Vaccine Group (WSAVVG)
Dr. Ronald David Schultz
Professor and Chair
Department of Pathobiological Sciences
School of Veterinary Medicine
University of Wisconsin-Madison
Corporate Sponsors include but are not limited to:
![]() |
![]() |
![]() |
Additional Corporate Sponsors will be listed in detail at a later time.
Sunday, July 19
12:00 Noon 5:30 PM
Introduction and General Topics
| 12:00 - 1:00 | Welcoming Ceremony |
| 1:00 - 1:45 | Tizard, Ian Dr. Ian Tizard, Professor, Texas A&M University, College Station, TX Variolation and vaccination in domestic animals the earliest attempts to protect against infectious diseases |
| 1:45 - 2:30 | Bergman, Philip Dr. Philip Bergman, BrightHeart Veterinary Centers, Armonk, NY Of Mice & Men (& Dogs!): Therapeutic Vaccines for Cancer?? |
| 2:30 - 3:15 | Kawaoka, Yoshi Dr. Yoshi Kawaoka, Department of Pathobiological Sciences, Influenza Research Institute, University of Wisconsin-Madison Why influenza kills and how to prevent it from killing again |
| 3:15 - 3:30 | Break |
| 3:30 4:15 | Cook, Mark Dr. Mark Cook, Department of Animal Sciences, University of Wisconsin-Madison Vaccination Taxation |
| 4:15 5:00 | Suresh, M. Dr. M. Suresh, Department of Pathobilogical Sciences, University of Wisconsin-Madison Cell Cycle Regulator p27Kip1 Constrains the Quantity and Quality of CD8 T Cell Memory by Regulating the Number of Memory Precursor Effector Cells |
| 5:00 – 5:30 | Walker, John Dr. John Walker, Pfizer Animal Health, Parkville Australia Peptide conjugate vaccines for immuno-contraception - commercialization by species |
| 5:30 - 6:00 | Q&A |
| 6:30 9:30 | Opening Reception |
Monday, July 20
Bovine AM Session A : 8:15 12:00
Co-Chairs: Dr. Pat Shewen and Dr. Jim Roth
| 8:15 8:30 | Intro by Co-Chairs |
| 8:30-9:00 | Collins, Mike Dr. Mike Collins, University of Wisconsin-Madison Johnes disease diagnostics: The right test at the right time for the right price |
| 9:00 9:30 | Talaat, Adel Dr. Adel Talaat, School of Veterinary Medicine, University of Wisconsin- Madison On the Road to Discovery of Novel Vaccines Against Johnes Disease in Cattle |
| 9:30 10:00 | Baldwin, Cynthia Dr. Cynthia Baldwin, Univ. of Mass, Dept. of Veterinary and Animal Science, Amherst MA Involvement of bovine gamma delta T cells in the immune response stimulated by a protective vaccine against Leptospira serovar Hardjo |
| 10:00 10:30 | Break |
| 10:30 11:00 | Kehrli, Marcus |
| 11:00 11:30 | Potter, Andrew Dr. Andrew Potter, Director and CEO, VIDO, Saskatoon, SK CANADA Vaccination as a tool to reduce shedding of shigatoxin-producing Escherichia coli by cattle |
| 11:30 12:00 | Q&A or Poster Oral Presentations |
| 12:00 1:30 | Lunch |
| Bovine PM Session: 1:30 5:30 Co-Chairs: Dr. Gerhardt Schurig and Dr. Marcus Kehrli |
|
| 1:30 1:45 | Intro by Co-Chairs |
| 1:45 2:15 | Corbeil, Lynette Dr. Lynette Corbeil, University of California-San Diego Histophilus somni IbpA: diagnostic, protective and toxic domains |
| 2:15 2:45 | Shewen, Patricia Dr. Patricia Shewen, Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario CANADA Vaccination of Neonatal Calves: Obstacles and Opportunities |
| 2:45 3:15 | Czuprynski, Chuck |
| 3:15 3:30 | Break |
| 3:30 4:00 | Roth, James Dr. James A. Roth, Director, Center for Food Security and Public Health Executive Director, Institute for International Cooperation in Animal Biologics, College of Veterinary Medicine, Iowa State University, Ames, Iowa 50011 Induction of T Cell-Mediated Immunity by Bovine Vaccines |
| 4:00 4:30 | Dubovi, Ed Dr. Edward Dubovi, NY State Diagnostic Laboratory, Cornell University Diagnostic Testing as a Key Component of a BVDV Control Program |
| 4:30 5:30 | Q&A or Poster Oral Presentations |
| Canine and Feline AM Session: 8:15 12:00 Co-Chairs: Dr. Max Appel and Dr. Fred Scott |
|
| 8:15 8:30 | Intro by Co-chairs |
| 8:30 9:00 | Lappin, Mike Dr. Mike Lappin, Department of Clinical Sciences, Colorado State University, Ft. Collins, CO Antibodies against feline tissues induced by vaccination |
| 9:00 9:30 | Lutz, Hans Dr. Hans Lutz, Head, Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland Diagnosis of Feline Leukemia Virus infection the basis for eradication |
| 9:30 10:00 | LaFleur, Rhonda Dr. Rhonda LaFleur, Intervet/Schering-Plough Animal Hlth, Elkhorn NE A Novel Borrelia burgdorferi Bacterin that induces both OSPA and OSPC Borreliacidal Antibodies Protects Dogs against Lyme Disease |
| 10:00 10:30 | Break |
| 10:30 11:00 | Pardo, Camila Dr. M. Camila Pardo, Merial, Athens GA Prevention of Canine leptospirosis and leptospiruria caused by L. grippotyphosa, 15 months after last vaccination |
| 11:00 11:30 | Martella, Vito Dr. Vito Martella, School of Veterinary Medicine, Bari, Italy Discovery of new canine enteric viruses |
| 11:30 12:00 | Q&A or Poster Oral Presentations |
| 12:00 1:30 | Lunch |
| Canine & Feline PM Session: 1:30 - 5:30 Co-Chairs: Dr. Gilles Chappius, Dr. Skip Carmichael |
|
| 1:15 1:45 | Carmichael, Leland (Skip) Dr. Leland (Skip) Carmichael, Baker Institute, Cornell University Canine parvovirus type-2: Then and 31 years later. |
| 1:45 2:15 | Wasmoen, Terri Dr. Terri Wasmoen, Sr. Director, Biological Research, Intervet/Schering Plough Inc., 21401 West Center Road, Elkhorn NE 68022 Canine Influenza Virus: Experimental disease and prevention with vaccination |
| 2:15 2:45 | Kapil, Sanjay Dr. Sanjay Kapil, Oklahoma State Univ., Diagnostic Lab, Stillwater OK Canine Parvovirus: An Emerging, Reemerging Significant Pathogen of Dogs |
| 2:45 3:15 | Dodds, W.J. Dr. Jean Dodds, Hemopet, Santa Monica, CA. Compliance or resistance to current vaccine guidelines? |
| 3:15 3:30 | Break |
| 3:30 4:00 | Ford, Rich Dr. Rich Ford, North Carolina State University, College of Vet Medicine "Post-vaccinal Ischemic Vasculitis in Dogs: Satellite Skin Lesions" |
| 4:00 4:30 | Moore, George Dr. George Moore, Purdue University, West Layfayette IN Antigenic Causes of Vaccine-Associated Allergic Reactions in Dogs |
| 4:30 5:00 | Osorio, J.E. Dr. Jorge Osorio, Department of Pathobiological Sciences, University of Wisconsin-Madison Development of oral raccoon pox based vaccines that protect black- tailed prairie dogs against plague |
| 5:00 5:30 | Decaro, Nicola Dr. Nicola Decaro, School of Veterinary Medicine, Bari, Italy An Update on Canine Coronaviruses |
| 5:30 6:00 | Q&A |
Tuesday, July 21
Canine/Feline AM Session: 8:15 12:00
Co-Chairs: Dr. Ilona Rodan, Dr. Mike Paul
| 8:15 - 8:30 | Intro by Co-Chairs |
| 8:30 9:00 | Leutenegger, Christian Dr. Christian Leutenegger, Idexx Laboratories, Sacramento, CA Molecular Diagnostics and Vaccination: Dealing with Interference and Rates of False Positive Results |
| 9:00 9:30 | Evermann, Jim Dr. James Evermann, Washington State University, Diagnostic Lab Evolution of a Diagnosis: The Technology is Changing, but the Basic Principles Remain the Same |
| 9:30 10:00 | Pedersen, Niels Dr. Niels Pedersen, UC-Davis, Davis CA Feline infectious Peritonitis Dilemmas of diagnosis, treatment and vaccination |
| 10:00 10:30 | Break |
| 10:30 11:00 | Leard, Tim Dr. Timothy Leard, Merial, Athens, GA Animal Health Vaccine, The Path to Licensure Canine Melanoma DNA Vaccine |
| 11:00 11:30 | Schultz, Ronald Dr. Ronald Schultz, Department of Pathobiological Sciences, University of Wisconsin-Madison Canine and Feline Vaccine Questions: Do We Have the Answers? |
| 11:30 12:00 | Q&A Roundtable |
| 12:00 1:30 | Lunch |
| Swine PM Session: 1:30 5:45 Co-Chairs: Dr. Joan Lunney and Dr. Chris Olsen |
|
| 1:30 1:45 | Intro by Chairs |
| 1:45 2:30 | Butler, J.E. Dr. J.E. Butler, Dept. of Microbiology, University of Iowa The effect of PRRSV, SIV and PCV-2 on the humoral immune system of germfree isolator piglets |
| 2:30 3:15 | Murtaugh, Michael Dr. Michael Murtaugh, Dept. of Veterinary and Biomedical Sciences, University of Minnesota Imunological Constraints on Vaccine Development for PRRS |
| 3:15 3:30 | Break |
| 3:30 4:15 | Saif, Linda Dr. Linda Saif, Food Animal Health Research Program, OARDC, Dept. Veterinary Preventive Med, The Ohio State University, Wooster, OH USA Gut reactions to rotavirus vaccines in a gnotobiotic piglet disease model: a priming lesion for neonatal mucosal immunity |
| 4:15 4:45 | Yoo, Han Sang Dr. Han Sang Yoo, Professor, Seoul National University A novel swine atrophic rhinitis vaccine candidate that induces mucosal immune responses by delivery systems based on chitosan microspheres |
| 4:45 5:15 | Thacker, Eileen Dr. Eileen Thacker, USDA-Agricultural Research Service, Beltsville MD The Autogenous Option |
| 5:15 5:45 | Vincent, Amy |
| Equine AM Session: 8:00 12:00 Co-Chairs: Dr. Dave Horohov, Dr. Paul Lunn |
|
| 8:00 8:30 | Intro by David Horohov, University of Kentucky |
| 8:30 9:15 | Hines, Steve Dr. Steve Hines, Washington State University, Pulllman, WA Rhodococcus equi - immunity and strategies for prevention |
| 9:15 9:45 | Adams, Amanda Dr. Amanda Adams, Maxwell H. Gluck Equine Research Center, University of KY Comparison of humoral and cell-mediated immune responses of young and old horses following influenza recombinant canarypox virus vaccination and challenge |
| 9:45 10:15 | Chang, Yu-Wei Dr. Yu-Wei Chang, Fort Dodge Animal Health Development and Registration of Fort Dodge Animal Healths West Nile Virus Vaccines |
| 10:15 10:30 | Break |
| 10:30 11:00 | Vaala, Wendy Dr. Wendy Vaala, Intervet/Schering Plough PreveNile and WNV prevention |
| 11:00 11:30 | Lunn, Paul Dr. Paul Lunn, Colorado State University New diseases, new vaccines, old challenges: the equine balance sheet |
| 11:30 12:00 | Q&A and/or poster presentations |
| 12:00 1:30 | Lunch |
| Equine PM Session: 1:30 5:30 Co-Chairs: Dr. Dave Horohov and Dr. Paul Lunn |
|
| 1:30 1:45 | Intro by Co-Chairs |
| 1:45 2:15 | Minke, Jules Dr. Jules Minke, Merial, Lyon France Field experience on ProteqFluฎ during the Australian outbreak |
| 2:15 2:45 | Osterrieder, Klaus Dr. Klaus Osterrieder, Institut fur Virologie, Freie Universitat Berlin Equine Herpesvirus Type 1 Novel Vectored Vaccines |
| 2:45 3:15 | Landolt, Gabi Dr. Gabi Landolt, Colorado State Univ., Ft. Collins, CO Past the Point of No Return? Of Horses, Dogs, and Influenza |
| 3:15 3:30 | Break |
| 3:30 4:00 | Timoney, John Dr. John Timoney, Professor, Dept. of Veterinary Science, Maxwell H. Gluck Equine Research Ctr., University of KY, Lexington, KY Genomes of Streptococcus equi and zooepidemicus: Rosetta stones for strangles vaccine improvement? |
| 4:00 4:30 | Stenbohm, Bob Dr. Bob Stenbohm, Boehringer Ingelheim, St. Joseph, Missouri Evaluation of the humoral immune response and fecal shedding in weaning foals following oral and intra-rectal administration of an avirulent live vaccine of Lawsonia intracellularis |
| 4:30 5:00 | Gershwin, Laurel Dr. Laurel Gershwin, Professor of Immunology, University of California- Davis Equine Vaccine Hypersensitivity |
| 5:00 5:30 | Q&A |
Wednesday, July 22
New technologies to design vaccines for the control and eradication of transboundary diseases (FAD) Session AM: 8:30 12:00
Co-Chairs: Dr. Cyril Gay, Dr. Paul-Pierre Pastoret
| 8:30 8:45 | Intro by Co-Chairs |
| 8:45 9:30 | Pastoret, Paul-Pierre Dr. Paul-Pierre Pastoret, OIE, World Organisation for Animal Health, Paris, France Vaccines in relation to trade and new and emerging technologies |
| 9:30 10:15 | Rodriguez, Luis Dr. Luis Rodriguez, USDA/ARS Plum Island Animal Disease Center The importance of basic research for the rational design of vaccines |
| 10:15 10:30 | Break |
| 10:30 11:00 | MacLachlan, Jim Dr. James MacLachlan, Department of Pathology, Microbiology and Immunology, UC-Davis Recombinant Canarypox Virus Vaccines to Prevent Emerging Orbivirus Diseases of Livestock |
| 11:00 11:30 | Vincent, Amy Dr. Amy Vincent, NADC, ARS, Ames IA New technologies to control Swine Influenza Virus |
| 11:30 12:00 | Posters |
| 12:00 1:30 | Lunch |
| New technologies to design vaccines for the control and eradication of transboundary diseases (FAD) Session PM: 1:00 4:30 Co-Chairs: Dr. Cyril Gay, Dr. Paul-Pierre Pastoret |
|
| 1:00 1:15 | Intro by Co-Chairs |
| 1:15 1:45 | Dr. Cyril Gay United States Dept. of Agriculture, Agriculture Research Service, Animal Production and Protection, Beltsville, Maryland New technologies to control Foot-and-Mouth Disease |
| 1:45 2:15 | Drew, Trevor Dr. Trevor Drew, Veterinary Laboratories Agency, Weybridge, England New technologies to control Classical Swine Fever (CSF) |
| 2:15 2:45 | Dungu, Baty Dr. Baty Dungu, GALVmed, Edinburgh, Scotland Prospects for improved Rift Valley Fever (RVF) vaccines |
| 2:45 3:00 | Break |
| 3:00 3:30 | Greenlee, Justin Dr. Justin Greenlee, Virus and Prion Diseases of Livestock Research Unit, National Animal Disease Center, Ames IA New Potentials in TSE diagnostics |
| 3:30 4:00 | Posters |
| 4:00 4:30 | Q&A |
| EVENING | Concert on the Square |
| Avian/Aquatic AM Session: 8:30 12:00 Co-Chairs: Dr. Phil Klesius and Dr. Stacey Schultz-Cherry |
|
| 8:30 8:45 | Intro by Co-Chairs |
| 8:45 9:30 | Afonso, Claudio Dr. Claudo Afonso, USDA-ARS, Southeast Poultry Research Lab, Athens, GA New strategies to control virulent Newcastle disease |
| 9:30 10:00 | Schultz-Cherry, Stacey Dr. Stacey Schultz-Cherry, Dept. Medical Microbiology, University of Wisconsin-Madison Astroviruses: Lessons learned from turkeys |
| 10:00 10:30 | Break |
| 10:30 11:00 | Saif, Mo Dr. Mo Saif, Ohio State University, Department of Animal Sciences, Columbus, OH Influenza Vaccines for Turkeys |
| 11:00 11:45 | Klesius, Phillip Dr. Phillip Klesius, United States Dept. of Agriculture, Agricultural Research Service, Aquatic Animal Health Research Laboratory, Auburn AL and Chestertown MD USA Fish Vaccines: Current State and Future Advances |
| 11:45 12:00 | Poster Session |
| 12:00 1:30 | Lunch |
| Avian/Aquatic PM Session: 1:30 4:30 Co-Chairs: Dr. Phil Klesius and Dr. Kathy Kurth |
|
| 1:30 1:45 | Intro by Co-Chairs |
| 1:45 2:15 | Adams, Alexandra Dr. Alexandra Adams, Institute of Aquaculture, Stirling, Scotland UK Novel approaches to fish vaccine development |
| 2:15 2:45 | Shoemaker, Craig Dr. Craig A. Shoemaker, USDA, Aquatic Animal Health Reseach Lab, Auburn AL Development and use of a modified live Flavobacterium columnare vaccine in fish |
| 2:45 3:15 | Kurth, Kathy Dr. Kathy Kurth, Wisconsin Veterinary Diagnostic Lab, Madison WI Emerging Aquatic Viruses in Wisconsin |
| 3:15 3:30 | Break |
| 3:30 4:00 | N. Mirhossenini Dr. N. Mirhosseini, Texas A&M University, College Station, TX Serologic and molecular diagnosis of avian borna virus infection. |
| 4:00 - 4:30 | Cook, Stephanie Dr. Stephanie Cook, Intervet Schering-Plough, Elkhorn, NE A Marek's Disease Virus Recombinant Vaccine to Control ILT and Marek's Disease Siumltaneously. |
| 4:30 5:00 | Q&A and/or poster presentations |
| EVENING | Concert on the Square |
Thursday, July 23
General Session: 8:30 11:45
Co-Chairs: Dr. Chuck Czuprynski and Dr. Gary Splitter
| 8:30 8:45 | Intro by Co-Chairs |
| 8:45 9:30 | Audonnet, Jean-Christophe Dr. Jean-Christophe Audonnet, Merial, Lyon France 20 years of experience with ALVAC as a vector for veterinary vaccines. |
| 9:30 10:15 | Rouse, Barry Dr. Barry Rouse, University of Tennessee-Knoxville Immunopathology versus immunity in viral infections |
| 10:15 11:00 | Bror Morein Dr. Bror Morein, Swedish University of Agricultural Sciences, Department of Veterinary Microbiology, Uppsala, Sweden ISCOM Technology: Its Importance in Designing Veterinary Vaccines |
| 11:00 11:45 | Meeusen, Els Dr. Els Meeusen, Animal Biotech Research Laboratory, Dept. of Physiology, School of Biomedical Sciences, Monash Univ, Victoria, Australia Adjuvants in the real world how do they work? |
| 11:45 1:00 | Lunch |
| General Session PM: 1:00 4:30 Co-Chairs: Dr. Gary Splitter and Dr. Els Meeusen |
|
| 1:00 1:15 | Intro by Co-Chairs |
| 1:15 2:00 | Lunney, Joan Dr. Joan Lunney, Animal Parasitic Diseases Lab, ANRI, ARS, USDA Genetic approaches to reveal immune response pathways and viral antigen targets for novel vaccine design |
| 2:00 2:45 | Splitter, Gary |
| 2:45 - 3:30 | Wiegers, Ann Dr. Ann Wiegers, CVB, APHIS, USDA, Ames, IA General Licensing Requirements for Veterinary Biologics in the United States |
| 3:30 4:00 | Trujillo, Jessie |
| 4:00 4:30 | Concluding Remarks Dr. Ronald D. Schultz |